Recap
Wall Street's Morning Calls: Top Upgrades, Downgrades and Price Target Hikes for Thursday, November 5, 2026
Upgrades, downgrades, initiations and price-target changes on notable names announced at 9:00 AM ET.
10
Notable Upgrades
10
Notable Downgrades
441
Total Research Notes
Notable Upgrades & Initiations
| Ticker | Firm | Action | Rating Shift | Price Target | Reason / Key Catalyst |
|---|---|---|---|---|---|
| ABB | RBC Capital | upgrade | Sector Perform → Outperform | Unchanged | Upgraded following fundamental review and favorable risk/reward setup. |
| ABB | Kepler Cheuvreux | upgrade | Hold → Buy | Unchanged | Upgraded following fundamental review and favorable risk/reward setup. |
| ABB | JP Morgan | upgrade | Underweight → Neutral | Unchanged | Upgraded following fundamental review and favorable risk/reward setup. |
| ACHR | Barclays | upgrade | Equal Weight → Overweight | $12.5 | Upgraded following fundamental review and favorable risk/reward setup. |
| ACNT | Sterne Agee | upgrade | Neutral → Buy | $18 | Upgraded following fundamental review and favorable risk/reward setup. |
| ADM | JP Morgan | upgrade | Underweight → Neutral | $84.75 | Upgraded following fundamental review and favorable risk/reward setup. |
| AEM | Freedom Broker | upgrade | Hold → Buy | $216.17 | Upgraded following fundamental review and favorable risk/reward setup. |
| AFYA | JP Morgan | upgrade | Neutral → Overweight | $17 | Upgraded following fundamental review and favorable risk/reward setup. |
| AGX | Lake Street | upgrade | Hold → Buy | $436.5 | Upgraded following fundamental review and favorable risk/reward setup. |
| AI | Northland Capital Markets | upgrade | Market Perform → Outperform | $16 | Upgraded following fundamental review and favorable risk/reward setup. |
Notable Downgrades & Cautious Calls
| Ticker | Firm | Action | Rating Shift | Price Target | Reason / Key Catalyst |
|---|---|---|---|---|---|
| AA | Argus Research | downgrade | Buy → Hold | $60.43 | Downgraded citing near-term execution risks and multiple compression. |
| AAP | Rothschild & Co | downgrade | Neutral → Sell | $48.64 | Downgraded citing near-term execution risks and multiple compression. |
| ABEV | B of A Securities | downgrade | Neutral → Underperform | $3.18 | Downgraded citing near-term execution risks and multiple compression. |
| ABEV | Scotiabank | downgrade | Sector Outperform → Sector Perform | $3.18 | Downgraded citing near-term execution risks and multiple compression. |
| ABOS | Citigroup | downgrade | Buy → Neutral | $7 | Downgraded citing near-term execution risks and multiple compression. |
| ABT | Argus Research | downgrade | Buy → Hold | $121.36 | Downgraded citing near-term execution risks and multiple compression. |
| ABVC | Maxim Group | downgrade | Buy → Hold | Unchanged | Downgraded citing near-term execution risks and multiple compression. |
| ACAD | UBS | downgrade | Buy → Neutral | $23 (cut from $49) | Price target lowered reflecting cautious valuation and margin headwinds. |
| ACH | Citigroup | downgrade | Buy → Neutral | $1.5 | Downgraded citing near-term execution risks and multiple compression. |
| ACI | JP Morgan | downgrade | Overweight → Neutral | $14 | Downgraded citing near-term execution risks and multiple compression. |
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.